Baxter’s Vivia home HD machine outside the US
Home HD trend lines outside the US are climbing! In England, about 4% of dialysis consumers use home HD (that’s about 4 times the US rate). Canada is at about 5%, and Sweden is close to 6%. In Australia,10% of people with ESRD use home HD. Baxter’s Vivia machine (approved in Europe but not yet in the US) is taking advantage of this trend.
Read the full article » | Posted 09-05-2014
Related Articles
- Proof of Concept for Silicon Nanopore Membrane Implantable HD Posted 10-05-2026
- AWAK PD To Go Posted 10-05-2026
- The Lancet Digital Health published results of Humacyte’s Phase III clinical trial of its V007 acellular tissue engineered vessel (ATEV) HD access Posted 09-18-2026
- Humacyte, Inc. announced Robert J. Kossman, MD, FACP, FASN and Prabir Roy-Chaudhury, MD, PhD, FASN have joined the company as advisors. Posted 08-21-2026

